Troikaa to set up injectable plant in Dehradun

Troikaa Pharmaceuticals Ltd, the Ahmedabad-based pharma company will set up injectable production facility targeting the therapeutic segment in domestic and export market.

Talking to Business Standard, Ketan Patel, Managing Director, Troikaa Pharma, said, "We will be setting up an injectable novel drug delivery system (NDDS) production facility in Dehradun."

The company will be investing Rs 12 crore for setting up its injectable NDDS production facility at the existing facility of the company at Dehradun in Uttaranchal. The entire funding for the project will be met from the internal accrual of the company.

Patel claims that the plant will be the first of its kind in the country coming up with innovative technology for the production of injectable NDDS. The injectable produced are not ordinary type but they are targeted at a niche area for application in various therapeutic segment.

"The new plant will be commissioned by November 2007," adds Patel. The company has already carried out in-house R&D for the injectable NDDS and has placed orders for the import of machinery from Europe and US.

"By October 2007, we will receive delivery of the machinery," informs Patel.

The company is tight-lipped over the technology that will be used for the production of injectable NDDS. Once the machinery are delivered, the company will apply for US Food & Drug Administration (FDA) for a licence.

"In March 2008, we will try to get our facility of the new injectable NDDS inspected for availing of USFDA approval for the facility clubbing the present facility of Deradhun," adds Patel.

The company is aiming to market the product in domestic market as well as in the overseas market. "In the first year of the operation, we expect to earn Rs 15-20 crore from the domestic market and Rs 10-15 crore from exports," adds Patel.

Initially, the company will start with one product of its injectable NDDS and then it will be followed by three different injectable NDDS products.